UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000007992
Receipt No. R000009406
Scientific Title Influence of Radiofrequency Ablation of Lung Cancer on Blood Perfusion in the Peripheral Lung Tissue and Lung Tumor: Evaluation with Dual Energy CT
Date of disclosure of the study information 2012/06/01
Last modified on 2017/11/24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Influence of Radiofrequency Ablation of Lung Cancer on Blood Perfusion in the Peripheral Lung Tissue and Lung Tumor: Evaluation with Dual Energy CT
Acronym Influence of Radiofrequency Ablation of Lung Cancer on Blood Perfusion in the Peripheral Lung Tissue and Lung Tumor: Evaluation with Dual Energy CT
Scientific Title Influence of Radiofrequency Ablation of Lung Cancer on Blood Perfusion in the Peripheral Lung Tissue and Lung Tumor: Evaluation with Dual Energy CT
Scientific Title:Acronym Influence of Radiofrequency Ablation of Lung Cancer on Blood Perfusion in the Peripheral Lung Tissue and Lung Tumor: Evaluation with Dual Energy CT
Region
Japan

Condition
Condition Lung Cancer
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate blood flow of the lung parenchyma and lung tumor after radiofrequency ablation with Dual Energy CT
Basic objectives2 Others
Basic objectives -Others Influence of radiofrequency ablation og lung cancer on blood perfusion in the peripheral lung tissue and lung tumor
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes To determine the incidence of decrease in blood perfusion in the peripheral lung tissue after radiofrequency ablation of lung cancer
Key secondary outcomes To determine the incidence of decrease in blood perfusion in the peripheral lung tumor after radiofrequency ablation of lung cancer

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine Device,equipment
Interventions/Control_1 When blood perfusion in the peripheral lung parenchyma decreases, pulmonary perfusion scintigraphy is performed to confirm the finding.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients who undergo RFA of lung tumor and provide informed consent for this study
Key exclusion criteria The patients with allergy to iodined constrast media
Target sample size 60

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kanazawa Susumu
Organization Okayama university Graduate school of Medicine, Dentistry and Pharmaceutical
Division name Department of Radiology
Zip code
Address 2-5-1 Shikata-cho Kita-ku Okayama
TEL 086-235-7313
Email

Public contact
Name of contact person
1st name
Middle name
Last name Tomita Koji
Organization Okayama University Hospital
Division name Department of Radiology
Zip code
Address 2-5-1 Shikata-cho Kita-ku Okayama
TEL 086-235-7313
Homepage URL
Email

Sponsor
Institute Okayama university Graduate school of Medicine, Dentistry and Pharmaceutical Department of Radiology
Institute
Department

Funding Source
Organization Bayer Yakuhin
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor None
Name of secondary funder(s) None

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 岡山大学病院(岡山県)

Other administrative information
Date of disclosure of the study information
2012 Year 06 Month 01 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 05 Month 31 Day
Date of IRB
Anticipated trial start date
2012 Year 06 Month 01 Day
Last follow-up date
2013 Year 12 Month 01 Day
Date of closure to data entry
2014 Year 01 Month 01 Day
Date trial data considered complete
2014 Year 01 Month 01 Day
Date analysis concluded
2014 Year 03 Month 01 Day

Other
Other related information

Management information
Registered date
2012 Year 05 Month 20 Day
Last modified on
2017 Year 11 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009406

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.